An innovation in skin brightening technology, the four products in the Lumixyl Brightening System work synergistically to target existing hyperpigmentation and to prevent its recurrence. For most patients these formulations can eliminate the need to use hydroquinone or its bi-products, which are controversial due to their potential side effects. Lumixyl products are proven to be powerful but gentle on skin.
For more information on Lumixyl in Canada please visit http://lumixyl.net/
Featuring the patented SCA technology, Endocare provides advanced regeneration and repair to address signs of aging and accelerate healing following dermatological treatments, including dermabrasion, laser treatments and chemical peels. SCA is a natural derived glycoprotein obtained from the Cryptomphalsus Aspersa species through a carefully controlled pharmacological process.
Co-Developed by Harvard University researchers, Heliocare's patented Fernblock active has been clinically shown to protect the skin from the harmful effects of sunlight. Taken daily, Heliocare carries out an antioxidant activity on the skin, inhibiting the damaging effects of free radicals, ultraviolet radiation and helping to maintain the appearance of healthy, youthful-looking skin.
Biretix’ novel patented RetinSphere complex provides the benefits of other formulations with significantly less irritation. Biretix has been marketed in Europe for the improvement of acne and acne-prone skin. A cosmeceutical in Canada, BiRetix offers tolerable, broad spectrum action formulated in four convenient and effective formats. Combined with a non-irritating alternative to alpha-hydroxy acids, RetinSphere offers a totally new approach that is tolerable, effective and safe to use even during summer months.